Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leendert A Trouw

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Autoimmunity Reviews|June 6, 2012
Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritisLeendert A Trouw, Michael Mahler
Expert Opinion on Biological Therapy|March 11, 2005
Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritisLeendert A Trouw, Mohamed R Daha
Immunology Letters|February 22, 2011
Role of complement in innate immunity and host defenseLeendert A Trouw, Mohamed R Daha
Rheumatology (Oxford, England)|August 12, 2010
Which elements of the criteria for RA are stable over time?Leendert A Trouw, Tom W J Huizinga
Nature Reviews. Rheumatology|September 16, 2016
Rheumatoid arthritis: Autoantibody testing to predict response to therapy in RALeendert A Trouw, Rene E M Toes
European Journal of Immunology|June 19, 2026
Shifting From Systemic to Precision-Targeted Complement Therapies: Opportunities and HurdlesMarco Mannes, Wioleta M Zelek, Leendert A Trouw
Immunobiology|May 1, 2026
Complement in tuberculosis infection and disease, a battle of two ancientsKarin Dijkman, Simone A Joosten, Leendert A Trouw
Frontiers in Immunology|May 30, 2013
Anti-C1q autoantibodies, novel tests, and clinical consequencesMichael Mahler, Rosanne A van Schaarenburg, Leendert A Trouw
Nature Reviews. Rheumatology|August 11, 2017
The complement system as a potential therapeutic target in rheumatic diseaseLeendert A Trouw, Matthew C Pickering, Anna M Blom
Nature Reviews. Rheumatology|March 10, 2017
Beyond citrullination: other post-translational protein modifications in rheumatoid arthritisLeendert A Trouw, Theo Rispens, Rene E M Toes
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Autoimmunity Reviews|June 6, 2012
Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritisLeendert A Trouw, Michael Mahler
Expert Opinion on Biological Therapy|March 11, 2005
Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritisLeendert A Trouw, Mohamed R Daha
Immunology Letters|February 22, 2011
Role of complement in innate immunity and host defenseLeendert A Trouw, Mohamed R Daha
Rheumatology (Oxford, England)|August 12, 2010
Which elements of the criteria for RA are stable over time?Leendert A Trouw, Tom W J Huizinga
Nature Reviews. Rheumatology|September 16, 2016
Rheumatoid arthritis: Autoantibody testing to predict response to therapy in RALeendert A Trouw, Rene E M Toes
European Journal of Immunology|June 19, 2026
Shifting From Systemic to Precision-Targeted Complement Therapies: Opportunities and HurdlesMarco Mannes, Wioleta M Zelek, Leendert A Trouw
Immunobiology|May 1, 2026
Complement in tuberculosis infection and disease, a battle of two ancientsKarin Dijkman, Simone A Joosten, Leendert A Trouw
Frontiers in Immunology|May 30, 2013
Anti-C1q autoantibodies, novel tests, and clinical consequencesMichael Mahler, Rosanne A van Schaarenburg, Leendert A Trouw
Nature Reviews. Rheumatology|August 11, 2017
The complement system as a potential therapeutic target in rheumatic diseaseLeendert A Trouw, Matthew C Pickering, Anna M Blom
Nature Reviews. Rheumatology|March 10, 2017
Beyond citrullination: other post-translational protein modifications in rheumatoid arthritisLeendert A Trouw, Theo Rispens, Rene E M Toes
Pageof 16